Obesity clinical trials
714 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
- Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
- Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
- Weight Bias Reducation Intervention With Nursing Students Using Simulation: The BRAVE Study
- Effect of Ketone Esters on Liver Fat Content and Metabolic Function
- Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
- Oxytocin for Weight Loss in Adolescents
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
- Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
- Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
- A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
- A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
- A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
- Phentermine's Impact on Treatment in Teens
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Lifestyle Intervention to Improve Muscle Function in Older Adults
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
- Sit Less, Interact and Move More (SLIMM) 2 Study
- Weight Management Intervention in College: A Pilot
- Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
- Pilot Testing a Novel Approach to Pediatric Obesity Treatment
- Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
- Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults
- TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
- Incretin Microdosing for Cardiometabolic Health in People With HIV
- The Effects of Exogenous Ketones on Cognitive Function
- Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
- Daily Eating Patterns for Total Health Study
- EBT Fruit and Vegetable Prescription
- An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
- Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
- Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
- Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Pain and Weight Treatment: Development and Trial of PAW
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Probiotic Intervention Study
- Family, Responsibility, Education, Support, and Health for Food Responsiveness
- First in Human Study in Subjects With Obesity, But Otherwise Healthy
- Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Obesity” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.